Skip to main content

PODD

Stock
Health Care
Medical Devices

Performance overview

PODD Price
Price Chart

Forward-looking statistics

Beta
0.80
Risk
35.35%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Company info

SectorHealth Care
IndustryMedical Devices
Employees3K
Market cap$13.4B

Fundamentals

Enterprise value$22.6B
Revenue$2.2B
Revenue per employee
Profit margin18.29%
Debt to equity131.41

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$5.54
Dividend per share
Revenue per share$31.34
Avg trading volume (30 day)$242M
Avg trading volume (10 day)$265M
Put-call ratio

Macro factor sensitivity

Growth-0.0
Credit+2.2
Liquidity+0.1
Inflation-2.1
Commodities+0.1
Interest Rates-2.3

Valuation

Dividend yield0.00%
PEG Ratio77.79
Price to sales9.63
P/E Ratio77.79
Enterprise Value to Revenue10.27
Price to book15.92

Upcoming events

Next earnings dayMay 9, 2025
Next dividend day
Ex. dividend day

News

Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?

Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research (July 9, 2025)
Insulet Posts Strong Q1 Results, Raises Forecasts On Momentum In US And Abroad

Insulet Corporation  PODD reported first-quarter adjusted earnings of $1.02 per share, beating the consensus of 80 cents.

Benzinga (May 9, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free